Established in 2021, Suzhou Olipharma Technology Co., Ltd. is specialized in providing global pharmaceutical companies with ‘one-stop’ oligonucleotide CRDMO services, such as oligonucleotide synthesis，process and analytical development, CMC services, API production and drug registration. 

3000 m2 GMP & ISO compliant pilot platform is equipped with nucleic acid synthesis, purification, and detection equipment such as AKTA OligoTM100/400/2000, focusing on oligonucleotide drug production process amplification and CMC pharmaceutical research.